Oats in a strictly gluten-free diet is associated with decreased gluten intake and increased serum bilirubin

e-SPEN

Volumn 4, Issue 6, 2009, Pages

  Løvik, Astrid ^a   Gjøen, Anne Ulla ^b   Mørkrid, Lars ^a   Guttormsen, Vigdis ^c   Ueland, Thor ^a   Lundin, Knut E A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO METROPOLITAN UNIVERSITY   (Norway)

Author keywords

Bilirubin; Dietary fibre intake; Gluten intake; Gluten free diet; Nutrient intake; Oats

Indexed keywords

BILIRUBIN; GLUTEN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CELIAC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY FIBER; FEMALE; GLUTEN FREE DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; OAT; OUTCOME ASSESSMENT; PROVOCATION TEST;

EID: 71949129241     PISSN: 17514991     EISSN: 17514991     Source Type: Journal    
DOI: 10.1016/j.eclnm.2009.09.002     Document Type: Article

References (28)

1. Fasano A., and Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120 (2001) 636-651
2. Janatuinen E.K., Pikkarainen P.H., Kemppainen T.A., Kosma V.M., Jarvinen R.M., Uusitupa M.I., et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 333 (1995) 1033-1037
3. Srinivasan U., Leonard N., Jones E., Kasarda D.D., Weir D.G., O'Farrelly C., et al. Absence of oats toxicity in adult coeliac disease. BMJ 313 (1996) 1300-1301
4. Storsrud S., Olsson M., Arvidsson L.R., Nilsson L.A., Nilsson O., and Kilander A. Adult coeliac patients do tolerate large amounts of oats. Eur J Clin Nutr 57 (2000) 163-169
5. Janatuinen E.K., Kemppainen T.A., Julkunen R.J., Kosma V.M., Maki M., Heikkinen M., et al. No harm from five year ingestion of oats in coeliac disease. Gut 50 (2002) 332-335
6. Peraaho M., Kaukinen K., Mustalahti K., Vuolteenaho N., Maki M., Laippala P., et al. Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study. Scand J Gastroenterol 39 (2004) 27-31
7. Holm K., Maki M., Vuolteenaho N., Mustalahti K., Ashorn M., Ruuska T., et al. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther 23 (2006) 1463-1472
8. Hogberg L., Laurin P., Falth-Magnusson K., Grant C., Grodzinsky E., Jansson G., et al. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 53 (2004) 649-654
9. Lundin K.E., Nilsen E.M., Scott H.G., Loberg E.M., Gjoen A., Bratlie J., et al. Oats induced villous atrophy in coeliac disease. Gut 52 (2003) 1649-1652
10. Arentz-Hansen H., Fleckenstein B., Molberg O., Scott H., Koning F., Jung G., et al. The molecular basis for oat intolerance in patients with celiac disease. PloS Med 1 (2004) 84-92
11. Halvorsen B.L., Holte K., Myhrstad M.C., Barikmo I., Hvattum E., Remberg S.F., et al. A systematic screening of total antioxidants in dietary plants. J Nutr 132 (2002) 461-471
12. Kosiak B., Torp M., Skjerve E., and Andersen B. Alternaria and Fusarium in Norwegian grains of reduced quality-a matched pair sample study. Int J Food Microbiol 93 (2004) 51-62
13. Guttormsen V., Løvik A., Bye A., Bratlie J., Mørkrid L., and Lundin K.E.A. No induction of anti-avenin IgA by oats in adult, diet treated coeliac disease patients. Scand J Gastroenterol 43 (2008) 161-165
14. Utviklingen i norsk kosthold. Matforsyningsstatistikk og Forbruks-undersøkelser 2007. Report No.: IS-1510). (Accessed August 20, 2009, at (2007), Sosial-og Helsedirektoratet, Oslo. http://www.helsedirektoratet.no/ernaering/publikasjoner/rapporter
15. Nilsen E.M., Jahnsen F.L., Lundin K.E., Johansen F.E., Fausa O., Sollid L.M., et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 115 (1998) 551-563
16. Tveito K., Brunborg C., Sandvik L., Loberg E.M., and Skar V. (13)C-xylose and (14)C-xylose breath tests for the diagnosis of coeliac disease. Scand J Gastroenterol 43 (2008) 166-173
17. Collin P., Thorell L., Kaukinen K., and Maki M. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease?. Aliment Pharmacol Ther 19 (2004) 1277-1283
18. Schofield W.N. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 39 Suppl. 1 (1985) 5-41
19. Goldberg G.R., Black A.E., Jebb S.A., Cole T.J., Murgatroyd P.R., Coward W.A., et al. Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording. Eur J Clin Nutr 45 (1991) 569-581
20. Rustad P., Felding P., Franzson L., Kairisto V., Lahti A., Mårtensson A., et al. The nordic reference interval project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 64 (2004) 271-284
21. Gibert A., Espadaler M., Angel C.M., Sanchez A., Vaque C., and Rafecas M. Consumption of gluten-free products: should the threshold value for trace amounts of gluten be at 20, 100 or 200 p.p.m. Eur J Gastroenterol Hepatol 18 (2006) 1187-1195
22. Grehn S., Fridell K., Lilliecreutz M., and Hallert C. Dietary habits of Swedish adult coeliac patients treated by a gluten-free diet for 10 years. Scand J Nutr/Näringsforskning 45 (2001) 178-182
23. Storsrud S., Hulthen L.R., and Lenner R.A. Beneficial effects of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences. Br J Nutr 90 (2003) 101-107
24. Nordic Nutrition Recommendations 2004. Integrating nutrition and physical activity. 4th ed. (2004), Nordic Council of Ministers, Copenhagen
25. Ciclitira P.J., Ellis H.J., and Lundin K.E. Gluten-free diet-what is toxic?. Best Pract Res Clin Gastroenterol 19 (2005) 359-371
26. Sadik R., Abrahamsson H., Kilander A., and Stotzer P.O. Gut transit in celiac disease: delay of small bowel transit and acceleration after dietary treatment. Am J Gastroenterol 99 (2004) 2429-2436
27. Probert C.S., Emmett P.M., and Heaton K.W. Some determinants of whole-gut transit time: a population-based study. QJM 88 (1995) 311-315
28. Erdogan D., Gullu H., Yildirim E., Tok D., Kirbas I., Ciftci O., et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 184 (2006) 431-437